Gastroesophageal Junction Region (GEJ) Cancer
1 clinical trials · Condition
◉ Watch Gastroesophageal Junction Region (GEJ) Cancer
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer (NCT02999295) | National Cancer Center, Japan | 2017-01-01 |
Track Gastroesophageal Junction Region (GEJ) Cancer automatically
Every clearance here is in the API, with alerts when new ones post.